Johnson & Johnson (JNJ) Tops Q2 EPS by 22c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
'Sunshine and Blue Skies' Ahead For Johnson & Johnson (JNJ) Following Strong Q2 Beat
July 21, 2021 9:53 AM EDTEarlier today, Johnson & Johnson (NYSE: JNJ) reported a strong Q2 beat both on the top and bottom lines: EPS of $2.48, $0.22 better than the analyst estimates of $2.26, and revenues of $23.31B versus the consensus estimate of $22.19B.
The company also revised its full-year guidance to the upside: FY2021 EPS of $9.60-$9.70, vs consensus of... More



